Mortal
发表于 2025-3-28 15:23:00
https://doi.org/10.1007/978-1-4613-0685-6 remarkable biological and clinical heterogeneity. Key mechanisms underlying CLL onset and progression have been recently dissected. Recent progresses led to the identification of a preneoplastic condition of the disease (i.e., monoclonal B-cell lymphocytosis, MBL) that shed light on very early even
外露
发表于 2025-3-28 20:12:54
http://reply.papertrans.cn/23/2264/226394/226394_42.png
谄媚于性
发表于 2025-3-29 00:14:46
https://doi.org/10.1007/978-3-658-40787-2edominantly a disease of the elderly with a preponderance of male patients. New evidence suggests that there are variations in gender incidence according to the clinical status of patients, with a higher male:female ratio in the groups with worse prognosis..Full blood counts and a physical examinati
glacial
发表于 2025-3-29 03:11:48
http://reply.papertrans.cn/23/2264/226394/226394_44.png
bromide
发表于 2025-3-29 09:57:42
https://doi.org/10.1007/978-3-658-40787-2road acceptance by physicians and investigators caring for patients with CLL. It is not the aim of the iwCLL guidelines to provide treatment recommendations, but definitions for the initial assessment, indication for treatment, and response assessment of CLL. Recent advances including the discovery
胆小懦夫
发表于 2025-3-29 15:14:58
http://reply.papertrans.cn/23/2264/226394/226394_46.png
四海为家的人
发表于 2025-3-29 17:02:50
Reflexion (der Gesellschaft) in Twitter, chromosome 17p (del17p) have a worse response to therapy and significantly shorter progression-free survival (PFS) and overall survival (OS). These genetic abnormalities occur in about 10% of untreated and up to 40% of previously treated patients and they define the “ultra-high risk” group among al
生命层
发表于 2025-3-29 21:02:58
https://doi.org/10.1007/978-3-663-02889-5 with first-line treatment, the treatment choice of relapsed CLL patients is dependent on several factors, including age, performance status, comorbidities, and duration of response to previous therapy. The outcome of second, and subsequent, lines of therapy is markedly improved by the addition of C
解脱
发表于 2025-3-30 02:01:03
http://reply.papertrans.cn/23/2264/226394/226394_49.png
offense
发表于 2025-3-30 05:56:19
Reflexion der Forschungsarbeit,are recognized, namely the diffuse large B-cell lymphoma (DLBCL) variant and the rare Hodgkin lymphoma (HL) variant. Histologic documentation is mandatory to diagnose RS. In the presence of clinical features suspicious of RS, diagnosis of transformation and choice of the site of biopsy may take adva